ASCO: Oxaliplatin does not improve outcomes for rectal cancer

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
520 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Jun 18, 2009

Dr. Carlo Aschele - E.O. Ospedali Galliera, Italy - speaking at the ASCO press conference: Adding oxaliplatin (Eloxatin) to standard treatment in patients with locally advanced rectal cancer does not improve tumour response. A preliminary analysis, however, suggests the treatment may reduce distant metastases.

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more